Clinical Trial Update: Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating national characteristics and outcome measures of gastroesophageal reflux disease patients using the PASS test to assess response to pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux | Phase 4 | Status: COMPLETED